Understand the Real Impact of UV Exposure
in Dermatology & Aesthetic Research
UV exposure is a critical but often unmeasured factor in dermatology and aesthetic studies. Without objective data, real-world sun exposure can introduce variability that affects treatment outcomes, safety, and study interpretation.
Replior’s RaySense UV sensor enables continuous, objective measurement of UV exposure and helping researchers better understand and control environmental impact in clinical studies.
Objective UV Data for Dermatology & Aesthetic Studies
UV exposure plays a significant role in skin health, influencing inflammation, pigmentation, skin quality, and treatment response. Despite this, patient sun behaviour is rarely measured objectively in clinical research.
By capturing continuous UV exposure data, the RaySense UV sensor helps researchers better understand how environmental exposure may influence study outcomes—and separate treatment effects from external factors.
Key Applications
Injectables & Aesthetic Procedures
UV exposure affects skin quality, pigmentation, and inflammation, potentially influencing perceived results in aesthetic treatments.
Laser & Energy-Based Treatments
Post-procedure UV exposure may impact both safety and results, including increased risk of hyperpigmentation and inconsistent treatment outcomes.
Phototherapy Trials
Clinical phototherapy relies on precise UV dosing. Uncontrolled ambient UV exposure between sessions can alter treatment response and confound dose–response relationships.
Injectables & Aesthetic Procedures
UV exposure affects skin quality, pigmentation, and inflammation, potentially influencing perceived results in aesthetic treatments.
Photoaging & Pigmentation
UV exposure is a key driver of photoaging, including actinic keratosis, solar lentigines, and uneven pigmentation. Objective UV exposure data helps separate treatment effects from patient sun behaviour.
Acne & Inflammatory Skin Diseases
(Acne, Atopic Dermatitis, Psoriasis, Rosacea)
UV exposure can influence inflammation and symptom severity, introducing variability in clinical outcomesand treatment response.
Why Measure Real-World UV Exposure?
When UV exposure is not measured objectively, it becomes difficult to determine whether study outcomes are driven by treatment effects or differences in participant behavior.
- Continuously measure real-world UV exposure
- Reduce reliance on subjective patient recall
- Identify UV-related variability across participants
- Improve interpretation of efficacy and safety results
- Strengthen confidence in study outcomes
Meet the Team
Replior will be attending the AMWC Conference in Monaco, where our team will be available to discuss how objective UV exposure data can support dermatology and aesthetic research
- 26-27-28 March, 2026
- Grimaldi Forum, Monaco Grimaldi Forum, Monaco
If you’re attending AMWC, we’d be happy to connect in person and explore how RaySense can strengthen your clinical studies and product performance.
If you’d like to schedule a meeting during the conference, or connect afterwards, feel free to reach out.
Linnea Hedström
Senior Business Developer
William Ahlström
Senior Business Developer
Resources
Meet us next at
16th Annual Outsourcing in Clinical Trials
Europe 2026